Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by DOINA IVAN and ALEXANDER LAZAR.
DOINA IVAN
Connection Strength
1.335
ALEXANDER LAZAR
  1. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma. J Cutan Pathol. 2010 Feb; 37(2):231-6.
    View in: PubMed
    Score: 0.345
  2. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2007 Jun; 34(6):474-80.
    View in: PubMed
    Score: 0.298
  3. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases. Mod Pathol. 2010 Apr; 23(4):567-73.
    View in: PubMed
    Score: 0.090
  4. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol. 2009 Nov; 22(11):1446-56.
    View in: PubMed
    Score: 0.087
  5. The usefulness of p63 detection for differentiating primary from metastatic skin adenocarcinomas. J Cutan Pathol. 2008 Sep; 35(9):880-1.
    View in: PubMed
    Score: 0.081
  6. Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus. Am J Dermatopathol. 2007 Oct; 29(5):462-6.
    View in: PubMed
    Score: 0.076
  7. Merkel cell tumor in a trichilemmal cyst: collision or association? Am J Dermatopathol. 2007 Apr; 29(2):180-3.
    View in: PubMed
    Score: 0.074
  8. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med. 2021 07 01; 145(7):842-850.
    View in: PubMed
    Score: 0.049
  9. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020 03; 33(3):496-513.
    View in: PubMed
    Score: 0.043
  10. Metastatic atypical fibroxanthoma: a series of 11 cases including with minimal and no subcutaneous involvement. Am J Dermatopathol. 2015 Jun; 37(6):455-61.
    View in: PubMed
    Score: 0.032
  11. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol. 2015 Feb; 135(2):508-515.
    View in: PubMed
    Score: 0.031
  12. Cutaneous digital papillary adenocarcinoma: a clinicopathologic study of 31 cases of a rare neoplasm with new observations. Am J Surg Pathol. 2012 Dec; 36(12):1883-91.
    View in: PubMed
    Score: 0.027
  13. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin. Am J Dermatopathol. 2010 Apr; 32(2):149-53.
    View in: PubMed
    Score: 0.023
  14. Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates. Mol Cancer Ther. 2009 Aug; 8(8):2079-85.
    View in: PubMed
    Score: 0.022
  15. Cellular blue nevi of the eyelid: A possible diagnostic pitfall. J Am Acad Dermatol. 2008 Feb; 58(2):257-60.
    View in: PubMed
    Score: 0.019
  16. Metastatic basal cell carcinoma exhibits reduced actin expression. Mod Pathol. 2008 May; 21(5):540-3.
    View in: PubMed
    Score: 0.019
  17. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma. J Cutan Pathol. 2007 May; 34(5):381-5.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.